Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Reesink-Peters

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|February 23, 2017
Authors' reply re: 'Word catheter and marsupialisation in women with a cyst or abscess of the Bartholin gland (WoMan-trial): a randomised clinical trial'Arjanne Kroese, Minke van der Velde, Leonard Morssink, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 4, 2012
[Vulvar basal cell carcinoma with destructive consequences]Janine L Blok, Nathalie Reesink-Peters, Gilles F H Diercks, et al.
The Journal of Infectious Diseases|May 2, 2003
HLA class I alleles and cervical neoplasiaJeroen T J Visser, Baukje Nynke Hoogeboom, Nathalie Reesink-Peters, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
An overview of innovative techniques to improve cervical cancer screeningEsther R Nijhuis, Nathalie Reesink-Peters, G Bea A Wisman, et al.
Cancers|August 12, 2023
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer PatientsGatske M Nieuwenhuyzen-de Boer, Hanane Aamran, Caroline B van den Berg, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
International Journal of Cancer|June 1, 2006
Assessment of gene promoter hypermethylation for detection of cervical neoplasiaG Bea A Wisman, Esther R Nijhuis, Mohammad O Hoque, et al.
Molecular Cancer Research : MCR|June 12, 2004
Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility studyNathalie Reesink-Peters, G Bea A Wisman, Carmen Jéronimo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancerNathalie Reesink-Peters, Jacobus van der Velden, Klaske A Ten Hoor, et al.
Gynecologic Oncology|December 27, 2021
Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trialBianca Reijntjes, Mieke van Suijlichem, Jorien M Woolderink, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BJOG : an International Journal of Obstetrics and Gynaecology|February 23, 2017
Authors' reply re: 'Word catheter and marsupialisation in women with a cyst or abscess of the Bartholin gland (WoMan-trial): a randomised clinical trial'Arjanne Kroese, Minke van der Velde, Leonard Morssink, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 4, 2012
[Vulvar basal cell carcinoma with destructive consequences]Janine L Blok, Nathalie Reesink-Peters, Gilles F H Diercks, et al.
The Journal of Infectious Diseases|May 2, 2003
HLA class I alleles and cervical neoplasiaJeroen T J Visser, Baukje Nynke Hoogeboom, Nathalie Reesink-Peters, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
An overview of innovative techniques to improve cervical cancer screeningEsther R Nijhuis, Nathalie Reesink-Peters, G Bea A Wisman, et al.
Cancers|August 12, 2023
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer PatientsGatske M Nieuwenhuyzen-de Boer, Hanane Aamran, Caroline B van den Berg, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
International Journal of Cancer|June 1, 2006
Assessment of gene promoter hypermethylation for detection of cervical neoplasiaG Bea A Wisman, Esther R Nijhuis, Mohammad O Hoque, et al.
Molecular Cancer Research : MCR|June 12, 2004
Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility studyNathalie Reesink-Peters, G Bea A Wisman, Carmen Jéronimo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancerNathalie Reesink-Peters, Jacobus van der Velden, Klaske A Ten Hoor, et al.
Gynecologic Oncology|December 27, 2021
Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trialBianca Reijntjes, Mieke van Suijlichem, Jorien M Woolderink, et al.
Pageof 1